Vetiqure is a pioneering brand dedicated to advancing cancer care for animals through innovative technology. A subsidiary of Scandinavian ChemoTech AB, Vetiqure specializes in Tumour Specific Electroporation™ (TSE), a patented method that provides an effective and non-invasive treatment for various types of tumors in pets. Their flagship product, the vetIQure™, utilizes a user-friendly and portable device that enhances traditional chemotherapy by enabling precise and controlled electrical field distribution. This innovative approach not only targets tumor cells effectively but also minimizes damage to surrounding healthy tissue.

Vetiqure is committed to ongoing research and development to refine their TSE technology and expand treatment efficacy, aiming to improve the lives of pets facing cancer. With sterile, single-use electrodes designed for optimal performance, Vetiqure ensures the highest standards of safety and efficacy in veterinary oncology. By focusing on patient-centered care, Vetiqure truly embodies the ethos that all life matters, striving to bring hope and healing to pet owners and their beloved companions.